Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

November 9, 2020

Study Completion Date

November 9, 2020

Conditions
Aerosol Generation and Droplet Dispersion and Deposition During Naso-gastric Intubation for Gastrointestinal Motility Investigations
Interventions
OTHER

Fluorescein

For droplet visualization, we will use fluorescein, which has been used for many years in medicine for diagnostic purposes and is safe upon topical administration, as a tracer. There are no local or systemic side effects of topical sodium fluorescein (5). Fluorescein is routinely used in the mouth to stain dental plaque (6). Through the lacrimal duct, the nasal cavity is exposed to fluorescein when it is used for ophthalmological purposes (7). Allergic reactions have been described to intravenous injection, which is not part of our trial. In the setting of head-and-neck and otolaryngological surgeries, coating the mouth with fluorescein has been used to quantify droplet spread, to assess for risk of transmission of COVID-19 (8). Hence, fluorescein can be safely applied to nasal and oropharyngeal cavities. We will use a similar approach, coating the nasal cavity, to study droplet spread from the nose during naso-gastric intubation for motility or reflux testing.

OTHER

Particle measurement

Quantification of aerosol will be done using a medical particle counter, as used for hospital safety measurements.

Trial Locations (1)

Unknown

TARGID, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT04687488 - Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations | Biotech Hunter | Biotech Hunter